您的购物车当前为空
Anti-CD59 Antibody是一种针对CD59(Protectin/MAC-IP)的人源化单克隆抗体。CD59是一种糖磷脂酰肌醇(GPI)锚定的补体调节蛋白,广泛表达于多种细胞表面,通过结合补体成分C8和C9,阻止膜攻击复合物(MAC/C5b-9)的最终组装,从而保护宿主细胞免受补体介导的裂解。在许多实体瘤和血液恶性肿瘤中,CD59呈过表达状态,帮助肿瘤细胞逃避免疫监视。Anti-CD59 Antibody通过特异性结合CD59并阻断其对MAC组装的抑制作用,恢复肿瘤细胞对补体的敏感性,诱导强效的补体依赖性细胞毒性(CDC)效应,是研究肿瘤免疫逃逸及开发增强型补体疗法的重要工具。
别名 抗CD59抗体
Anti-CD59 Antibody是一种针对CD59(Protectin/MAC-IP)的人源化单克隆抗体。CD59是一种糖磷脂酰肌醇(GPI)锚定的补体调节蛋白,广泛表达于多种细胞表面,通过结合补体成分C8和C9,阻止膜攻击复合物(MAC/C5b-9)的最终组装,从而保护宿主细胞免受补体介导的裂解。在许多实体瘤和血液恶性肿瘤中,CD59呈过表达状态,帮助肿瘤细胞逃避免疫监视。Anti-CD59 Antibody通过特异性结合CD59并阻断其对MAC组装的抑制作用,恢复肿瘤细胞对补体的敏感性,诱导强效的补体依赖性细胞毒性(CDC)效应,是研究肿瘤免疫逃逸及开发增强型补体疗法的重要工具。


TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
| 产品描述 | Anti-CD59 Antibody is a humanized monoclonal antibody targeting CD59 (Protectin/MAC-IP). CD59 is a GPI-anchored complement regulatory protein widely expressed on cell surfaces. It protects host cells from complement-mediated lysis by binding to complement components C8 and C9, thereby preventing the final assembly of the Membrane Attack Complex (MAC/C5b-9). CD59 is often overexpressed in various solid tumors and hematologic malignancies, enabling tumor cells to evade immune surveillance. This antibody specifically binds to CD59, blocking its inhibition of MAC assembly to restore tumor cell sensitivity to complement and induce potent Complement-Dependent Cytotoxicity (CDC). It serves as a critical tool for investigating tumor immune evasion and developing enhanced complement-based immunotherapies. |
| 别名 | 抗CD59抗体 |
| 反应种属 | Human |
| 应用 | ELISAFACSFunctional assay |
| 抗体种类 | Monoclonal |
| 缓冲液 | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| 内毒素 | <1.0 EU/mg |
| 同型 | IgG1 |
| 偶联 | Unconjugated |
| Uniprot ID | |
| 靶点 | CD59 |
| 存储 | Store at -20°C Shipping with blue ice/Shipping at ambient temperature. 实际储存温度请以COA为准 |
对于不同动物的给药剂量换算,您也可以参考 更多